Meningioma

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

Embolization for Meningioma

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)

Selumetinib for NF2-Related Schwannomatosis

Luvometinib in Combination With Serplulimab for NF2-Related Tumors

Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggressive Meningiomas: Proof-of-concept Study

PREselection of Patients at Risk for COgnitive DEcline After Radiotherapy Using Advanced MRI

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma

Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial

IN10018 in Combination With Dalpiciclib for Progressive Meningiomas

Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors

Cognitive Status After Removal of Skull Base Meningioma

Long-Term Longitudinal QoL in Patients Undergoing EEA

Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures

Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma